Related Experiment Video
Updated: Aug 19, 2025
06:24
Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies
Published on: January 10, 2025
870
Long vs Short Acting Testosterone Treatments: A Look at the Risks
Aaron A Gurayah1, Alexandra Dullea2, Alexander Weber1
1University of Miami Miller School of Medicine, Miami, FL.
Urology
|December 1, 2022
Summary
Testosterone therapy (TT) effectively treats deficiency, but risks vary. Short-acting TT mimics natural hormones but requires frequent dosing, while long-acting TT offers better adherence but may cause supraphysiologic levels.
Area of Science:
- Endocrinology
- Pharmacology
- Men's Health
Background:
- Testosterone therapy (TT) prescriptions are rising for testosterone deficiency.
- Patient counseling requires understanding risks of different TT modalities.
Purpose of the Study:
- To review and evaluate the risks associated with various testosterone therapy treatment modalities.
- To provide evidence for improved patient counseling regarding TT.
Main Methods:
- Literature review of existing studies on short-acting and long-acting testosterone therapy.
- Comparative analysis of treatment efficacy, physiological mimicry, dosing frequency, adherence, and potential side effects.
Main Results:
- Both short-acting and long-acting TT restore testosterone levels and improve deficiency symptoms.
- Short-acting TT closely mimics natural physiology but demands multiple daily doses.
- Long-acting TT improves patient adherence but risks supraphysiologic testosterone levels and adverse outcomes.
Conclusions:
- Understanding the distinct risk-benefit profiles of TT is crucial for effective patient management.
- Tailoring TT modality selection to individual patient needs and risk tolerance is recommended.
More Related Videos
11:51Combining Behavioral Endocrinology and Experimental Economics: Testosterone and Social Decision Making
Published on: March 2, 2011
15.2K
07:25A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
13.2K
Related Concept Videos
01:16Insulin: Dosing Regimen and Adverse Effects
226
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
226
01:20Disorders of the Male Reproductive System
522
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
522
01:26Testosterone: Functions and Regulation
921
The intricate hormonal interplay essential for male reproductive health begins with the release of gonadotropin-releasing hormone (GnRH) by the hypothalamus. This hormone prompts the pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). LH targets the Leydig cells in the testes, stimulating them to produce and release testosterone. In concert with testosterone, FSH acts on the Sertoli cells within the seminiferous tubules to facilitate the release of...
921
01:27Signs of Puberty
550
Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
550
01:27Insulin Formulations: Types and Delivery
250
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
Short-acting insulins are divided into...
250
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
341
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
341